|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate: | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Development costs and construction in progress | ||||||||||||||||||||
| Land and improvements | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Net real estate | ||||||||||||||||||||
| Loans receivable, net of reserves of $8,165 and $11,345 | ||||||||||||||||||||
| Investments in unconsolidated joint ventures | ||||||||||||||||||||
| Accounts receivable, net of allowance of $3,523 and $2,018 | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Right-of-use asset | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Bank line of credit and commercial paper | ||||||||||||||||||||
| Term loans | ||||||||||||||||||||
| Senior unsecured notes | ||||||||||||||||||||
| Mortgage debt | ||||||||||||||||||||
| Intangible liabilities | ||||||||||||||||||||
| Liabilities related to assets held for sale | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Accounts payable, accrued liabilities, and other liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interests | ||||||||||||||||||||
| Common stock, $1.00 par value: 1,500,000,000 shares authorized; 689,465,312 and 695,036,731 shares issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Cumulative dividends in excess of earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Public investors of Janus Living, Inc. | ||||||||||||||||||||
| Joint venture partners | ||||||||||||||||||||
| Non-managing member unitholders | ||||||||||||||||||||
| Total noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
